This trial is conducted in Asia. The aim of this trial is to compare the efficacy and safety
of insulin degludec/liraglutide and insulin degludec both in combination with metformin in
Japanese subjects with type 2 diabetes mellitus inadequately controlled with basal or
pre-mix/combination insulin therapy and oral anti-diabetic drugs.